Approach to childhood asthma in the era of COVID-19: The official statement endorsed by the Saudi Pediatric Pulmonology Association (SPPA).
Asthma
COVID-19
COVID-19, Coronavirus. Novel Coronavirus-2019
MDI, Metered dose inhaler
PPE, Personal protective equipment
SINA, The Saudi Initiative for Asthma
SPPA, Saudi Pediatric Pulmonology Association
STS, The Saudi Thoracic Society
Saudi pediatric pulmonology association (SPPA)
VHC, Valved holding chamber
WAP, Written Action Plan
Journal
International journal of pediatrics & adolescent medicine
ISSN: 2352-6467
Titre abrégé: Int J Pediatr Adolesc Med
Pays: Netherlands
ID NLM: 101670718
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
25
8
2020
medline:
25
8
2020
entrez:
25
8
2020
Statut:
ppublish
Résumé
Coronaviruses are a large family of viruses that infect humans, which may result in mild symptoms similar to those of the common cold. COVID-19 is most recent subtype similar or even worse than the two previous pandemic strains which were the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The first cases of COVID-19 emerged in December 2019. Since then, the virus causing the disease has infected more than four million people around the globe and led to hundreds of thousands deaths. We think addressing the management of asthma in the era of this pandemic is important for several reasons: high prevalence of asthma in Saudi Arabia, further, majorities were uncontrolled disease. The statement will provide special instructions and answers to common questions of physicians dealing with asthmatic children during this pandemic.
Identifiants
pubmed: 32838011
doi: 10.1016/j.ijpam.2020.07.001
pii: S2352-6467(20)30061-2
pmc: PMC7354375
doi:
Types de publication
Journal Article
Langues
eng
Pagination
103-106Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2020 Publishing services provided by Elsevier B.V. on behalf of King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Eur J Pediatr. 2011 Jun;170(6):709-18
pubmed: 20931226
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):281-9
pubmed: 25493535
Ann Thorac Med. 2019 Jan-Mar;14(1):3-48
pubmed: 30745934
J Hosp Infect. 2006 Oct;64(2):100-14
pubmed: 16916564
World Allergy Organ J. 2020 May 14;13(5):100125
pubmed: 32411315
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Lung India. 2015 Jul-Aug;32(4):359-66
pubmed: 26180386
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
J Clin Med. 2020 May 21;9(5):
pubmed: 32455807
Int J Pediatr Adolesc Med. 2014 Sep;1(1):26-30
pubmed: 32289071
J Allergy Clin Immunol. 2020 Jul;146(1):110-118
pubmed: 32294485
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
Am J Respir Crit Care Med. 2011 Jan 15;183(2):195-203
pubmed: 20802165
World J Pediatr. 2020 Jun;16(3):251-259
pubmed: 32193831
Int J Pediatr Adolesc Med. 2019 Jun;6(2):74-77
pubmed: 31388551
Int J Pediatr Adolesc Med. 2020 Jun;7(2):61-63
pubmed: 32426444
Trials. 2012 Nov 20;13:216
pubmed: 23164151
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Plast Reconstr Surg. 2011 Jul;128(1):305-10
pubmed: 21701348
J Psychosom Res. 2017 Feb;93:76-82
pubmed: 28107897
Allergy. 2020 Mar 31;:
pubmed: 32233040
Rhinology. 2020 Jun 1;58(3):302-303
pubmed: 32319971
Paediatr Child Health. 2014 Aug;19(7):362-6
pubmed: 25332675
Saudi Med J. 2008 May;29(5):714-7
pubmed: 18454220
Rev Paul Pediatr. 2018 Jul-Sep;36(3):364-371
pubmed: 29995144